The first gene therapy for children with Duchenne muscular dystrophy has been approved by the U.S. Food and Drug Administration. The therapy can be used in 4- and 5-year-olds with the degenerative ...
MARYLAND HEIGHTS, Mo. — Nothing lifts your spirits, quite like lifting someone else's. That's what they do every day at MDA Camp. "It's somewhere where you're not defined by your disease," said ...